InspireMD, Inc.

For the period ended Jun 30, 2025. Filed Aug 4, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 4, 2025

NSPR$0.71+2.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Changes in Equity

Common stock · Preferred C shares · Additional paid-in · Accumulated · Total
	Shares	Amount	Shares	Amount	capital	deficit	equity
BALANCE AT January 1, 2024	21,841,215	2	1,718	-*	261,000	(221,501)	39,501
Net loss			-	-	-	(14,941)	(14,941)
Exercise of pre-funded warrants	1,528,390	-*					-*
Exercise of Warrants Series H to 12,621,090 pre-funded warrants and 292,996 common stock, net of $1,000 issuance costs	292,996	1			16,853		16,854
Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of 112,382 shares	1,533,878	-*			5,349		5,349
BALANCE AT June 30, 2024	25,196,479	3	1,718	-*	283,202	(236,442)	46,763

*	Represents an amount less than $1 thousand

Common stock · Preferred C shares · Additional paid-in · Accumulated · Total
	Shares	Amount	Shares	Amount	capital	deficit	equity
BALANCE AT April 1, 2024	23,412,385	2	1,718	-*	263,618	(228,533)	35,087
Net loss			-	-	-	(7,909)	(7,909)
Exercise of pre-funded warrants	1,528,390	-*					-*
Exercise of Warrants Series H to 12,621,090 pre-funded warrants and 292,996 common stock, net of $1,000 issuance costs	292,996	1			16,853		16,854
Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of 37,292 shares	(37,292)	-*			2,731		2,731
BALANCE AT June 30, 2024	25,196,479	3	1,718	-*	283,202	(236,442)	46,763

*	Represents an amount less than $1 thousand

Common stock · Preferred C shares · Additional paid-in · Accumulated · Total
	Shares	Amount	Shares	Amount	capital	deficit	equity
BALANCE AT January 1, 2025	26,611,033	3	1,718	-*	289,589	(253,506)	36,086
Net loss	-	-	-	-	-	(24,317)	(24,317)
Exercise of pre-funded warrants**	1,411,553	-*					-*
Issuance of common stock, included at the market offering net of $22 issuance costs	273,621	-*			696		696
Exercise of Warrants Series I to common stock, net of $109 issuance costs	1,408,752	-*			1,838		1,838
Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of 288,207 shares	2,847,929	-*			5,940		5,940
BALANCE AT June 30, 2025	32,552,888	3	1,718	-*	298,063	(277,823)	20,243

*	Represents an amount less than $1 thousand

**	Represents cashless exercise of pre-funded warrants

Common stock · Preferred C shares · Additional paid-in · Accumulated · Total
	Shares	Amount	Shares	Amount	capital	deficit	equity
BALANCE AT April 1, 2025	29,752,661	3	1,718	-*	293,014	(264,672)	28,345
Net loss			-	-	-	(13,151)	(13,151)
Exercise of pre-funded warrants**	767,693	-*					-*
Exercise of Warrants Series I to common stock, net of $109 issuance costs	1,408,752	-*			1,838		1,838
Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of 258,912 shares	623,782	-*			3,211		3,211
BALANCE AT June 30, 2025	32,552,888	3	1,718	-*	298,063	(277,823)	20,243

*	Represents an amount less than $1 thousand

**	Represents cashless exercise of pre-funded warrants

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.